CAPE attenuates oxidative stress and neurotoxicity by modulating MAPK and Akt/glycogen synthase kinase 3β (GSK3β)-signaling pathways and reducing dead hippocampal cells in an AD mouse model. This evidence concerns the gene AKT1 and Alzheimer disease.